Common Contracts
1 similar Master Clinical Trial Agreement contracts
THIRD AMENDMENT TO THE MASTER CLINICAL TRIAL AGREEMENTMaster Clinical Trial Agreement • September 17th, 2014
This Third Amendment (“Third Amendment”) effective as of September 16, 2014 hereby amends the Master Clinical Trial Agreement dated March 16, 2009, Amendment #1 thereto dated May 31, 2012, and Amendment #2 thereto dated March 16, 2014, between The University of Texas Health Science Center at San Antonio, The University of Texas Health Science Center at Houston, The University of Texas Southwestern Medical Center, The University of Texas Medical Branch at Galveston, The University of Texas Health Science Center at Tyler and The University of Texas at Austin, (individually and collectively referred to as an “Institution”) and Hoffmann-La Roche Inc. and Roche Laboratories Inc. (each referred to as “Roche”) (the “Master Agreement (as amended)”) (each a “Party” and collectively the “Parties”).
